Skip to main content
Supplement ScienceSupplementScience

Benefits of Saffron (Macular Health)

Evidence:Emerging
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • AMD visual acuity — a 2010 RCT by Falsini et al. (n=25) found 20 mg/day saffron improved macular function (focal ERG) and visual acuity in early AMD after just 3 months
  • Retinal neuroprotection — crocin and crocetin protect photoreceptors from light-induced apoptosis by inhibiting caspase-3 activation and reducing oxidative stress markers
  • Anti-inflammatory effects — saffron supplementation reduced IL-6 and TNF-α levels in retinal tissue in preclinical models of retinal degeneration
  • Long-term macular benefits — a 15-month follow-up study showed sustained visual acuity improvements with continued saffron supplementation at 20 mg/day

What the Research Says

Saffron (Macular Health) is emerging as a promising therapeutic option for early age-related macular degeneration (AMD). Falsini et al. (2010) conducted a randomized, double-blind study involving 25 early AMD patients and found that saffron supplementation significantly improved retinal flicker sensitivity compared to placebo over a 3-month period. These findings were further supported by Piccardi et al. (2012), who reported sustained benefits in retinal flicker sensitivity and visual acuity in 29 early AMD patients following 20 mg/day saffron supplementation over 14 months.

Additionally, Marangoni et al. (2013) demonstrated that saffron supplementation improved focal ERG amplitude and sensitivity in early AMD patients, with no influence from CFH or ARMS2 genotypes. This study involved 33 participants and highlighted the potential of saffron as a genotype-independent intervention for macular health.

While the sample sizes in these studies remain relatively small, the consistent positive outcomes across multiple trials underscore the potential of saffron as a beneficial supplement for early AMD patients.

References

  1. RCTFalsini B, Piccardi M, Minnella A, et al. (2010). Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Investigative Ophthalmology & Visual Science. DOI PubMed
  2. ObservationalPiccardi M, Marangoni D, Minnella AM, et al. (2012). A longitudinal follow-up study of saffron supplementation in early age-related macular degeneration. Evidence-Based Complementary and Alternative Medicine. DOI PubMed
  3. RCTMarangoni D, Falsini B, Piccardi M, et al. (2013). Functional effect of saffron supplementation and risk genotypes in early age-related macular degeneration. Nutrients. DOI PubMed